Loading...

    Mentions of

    sorted by publishing date

    Last Edited: 14 days ago

    Multi-Agency Foresight with One Health ApproachFebruary 2026

    Final report

    This external scientific report is the final deliverable of a Foresight on Demand pilot that explored how multi-agency foresight, grounded in a One Health perspective, can strengthen the EU's capacity for anticipatory governance. Led by EFSA, the work was carried out with members of the EU-ANSA Futures Cluster, ECHA, Frontex and the Joint Research Centre, and combined horizon scanning, scenario development, participatory workshops, surveys and interviews.

    The report first scopes the policy context and the One Health themes relevant to EU agencies, and analyses over 1,100 factors of change identified through AI-assisted horizon scanning. It then presents five scenarios for 2035, complemented by AI-assisted scenarios: Health Transformation after Wake-up Call; Better safe than sorry: Nature-Smart Europe in the Age of Prevention; One Health Governance in a Digitalised, Climate-Challenged Europe; Nationalism and egocentrism in Europe; and Keep it private! Building on a workshop with EU agency representatives in Lisbon in November 2025, it sets out four strategic areas for collaboration and four proposals for multi-agency foresight, on future risk modelling and digital twins, equitable and just health systems in 2035, One Health governance and data integration, and the melting of the Arctic and its implications for One Health.

    Across the scenarios, technology is not the main determinant of resilience; data governance, trust and coordination are. The report proposes an adaptive, modular approach in which agencies lead and co-produce foresight modules, with the EU-ANSA Futures Cluster acting as curator of a foresight portfolio. It closes with 12 cross-cutting recommendations, including a shared horizon-scanning module, foresight cycles aligned with Commission and agency planning, the systematic integration of equity and social determinants, and the use of AI as an assistive layer rather than a substitute for human sense-making.

    Könnölä, T., Ferrari, A., Giesecke, S., Cuhls, K., & Banchs-Piqué, M. (2026). Multi-agency foresight with One Health approach. Deliverable 5: Final report (EFSA Supporting Publication 2026:EN-10045). European Food Safety Authority. https://doi.org/10.2903/sp.efsa.2026.EN-10045 

    Posted on: 02/11/2026

    Last Edited: 14 days ago

    Multi-Agency Foresight with One Health Approach1January 2025 - February 2026

    Multi-Agency Foresight with One Health Approach

    Cross-border threats and systemic risks at the intersection of human, animal and environmental health increasingly interact and amplify each other, driven by climate change, environmental degradation, technological transformation and geopolitical uncertainty. No single EU agency can anticipate such dynamics alone. Led by the European Food Safety Authority (EFSA), this Foresight on Demand project piloted a multi-agency foresight process with a One Health approach for the EU-ANSA Futures Cluster, in close interaction with the European Union Drugs Agency (EUDA), ECHA, Frontex and the Joint Research Centre. The work was carried out under the Foresight on Demand framework contract of DG Research and Innovation by a team from the Insight Foresight Institute, AIT, Fraunhofer IS and VTT.

    The process moved from scoping and shared framing to AI-assisted horizon scanning, which yielded over 1,100 factors of change (trends, weak signals and wild cards) across PESTEL categories, clustered into themes for scenario work. Scenario workshops and AI-assisted morphological scenario building produced a set of scenarios for 2035, ranging from 'Better safe than sorry: Nature-Smart Europe in the Age of Prevention' to 'Nationalism and egocentrism in Europe'. At a sense-making workshop in Lisbon in November 2025, representatives of EU agencies developed shared 2035 visions for four strategic areas and stress-tested them against contrasting scenarios: future risk modelling and digital twins; health, equity and demographics; security, resilience, climate crisis and public engagement; and One Health governance and data use.

    The work shows that the main bottlenecks are institutional rather than methodological: fragmented data governance, misaligned mandates and planning cycles, uneven capacity and, above all, trust and legitimacy. The same technologies can enable prevention and coordination or intensify surveillance and inequity, depending on governance. The project therefore proposes an adaptive, modular approach in which agencies lead and co-produce joint foresight modules, such as shared horizon scanning, scenario building and roadmapping, so that multi-agency foresight becomes a standing capability rather than a one-off exercise.

    Final report (EFSA Supporting Publications, 2026): https://doi.org/10.2903/sp.efsa.2026.EN-10045 

    Posted on: 02/11/2026

    Last Edited: 9 months ago

    Promoting Outcomes of the EUDA Synthetic Drugs Deep Dive1November 2025 - October 2026

    In 2025, the European Union Drugs Agency (EUDA) completed the project Synthetic Drugs 2050 to address increasing uncertainty surrounding the future production, distribution, and use of synthetic drugs in Europe up to 2050. Using horizon scanning, trend analysis, and sense-making approaches, the Foresight on Demand (FOD) project team and EUDA jointly developed four plausible scenarios to support EU-level and national stakeholders in anticipating emerging risks, identifying opportunities, and reinforcing the resilience of future policies.

    The 2026 FOD–EUDA project marks the second phase of this foresight work and will focus on:

    • Transforming the 2050 scenarios into interactive tools that foster strategic thinking
    • Developing participatory formats that make complex foresight insights accessible and engaging
    • Formulating recommendations for embedding foresight practices into EUDA’s strategic planning and policy development

    The project will deliver:

    • A Scenario Activation Toolkit with interactive resources
    • Participatory testing and validation workshops with key stakeholders
    • A final project report, including a toolkit manual and consolidated insights on the project’s outcomes

    Posted on: 18/02/2026

    Last Edited: 9 months ago

    Synthetic Drugs 20501December 2024 - November 2025

    Increasing EU resilience to future developments in the availability and use of synthetic drugs by 2050

    The European Union Drugs Agency’s (EUDA) project “Synthetic Drugs 2050” addressed the growing uncertainty surrounding the future availability, spread, and use of synthetic drugs in Europe up to 2050. Synthetic drugs represent a rapidly evolving and systemic challenge for Europe, affecting public health, security, social cohesion, productivity, and overall wellbeing. Accelerated technological change, globalised supply chains, digitalisation, and increasingly blurred boundaries between legal, illegal, controlled, and uncontrolled substances further amplify the complexity of this issue.


    The project applied a participatory strategic foresight approach to explore possible futures of synthetic drugs in Europe, moving beyond short-term monitoring and reactive policy responses. By systematically analysing global and regional drivers of change, emerging trends, weak signals, and deep uncertainties, the project built a shared understanding of how synthetic drugs markets, uses, and impacts may evolve in the medium- and long-term.

    Through horizon scanning, trend analysis, scenario building, and sense-making activities, Synthetic Drugs 2050 supports EU-level and national stakeholders in anticipating risks, identifying opportunities, and strengthening policy resilience. The project explicitly linked foresight insights to strategic reflection, policy options, and research priorities, while embedding capacity-building components to enhance futures literacy and long-term preparedness within the EU drug policy ecosystem.

    Objectives

    The Synthetic Drugs 2050 project encompassed:

    • A comprehensive, methodologically robust foresight study on the future availability and use of synthetic drugs in Europe up to 2050, exploring systemic drivers, uncertainties, and disruptive developments across social, technological, economic, environmental, political, legal, and ethical dimensions.
    • Development of multiple plausible future scenarios describing how synthetic drugs diffusion in Europe could evolve by 2050, challenging prevailing assumptions and highlighting non-obvious risks and opportunities.
    • Mapping of first-, second-, and third-order implications of synthetic drugs diffusion across Europe, identifying cause–effect pathways, time-bound consequences, and cross-sectoral impacts on health, public safety, governance, and society.
    • Support for strategic preparedness and policy resilience by co-developing policy responses, strategic options, and research and innovation priorities at EU and national levels.
    • Further development of strengthened foresight capacity and futures literacy within EUDA and its stakeholder community through learning-by-doing, participatory engagement, and the development of reusable foresight tools and frameworks.

    Outputs

    • Horizon scanning and trend analysis reports
    • A set of four future scenarios for synthetic drugs in Europe by 2050
    • A mapped system of time-bound implications and cause–effect pathways
    • Policy responses and strategic recommendations
    • A foresight manual and horizon scanning framework for future use

    Find more information here: https://www.euda.europa.eu/index_en

    Posted on: 18/02/2026